Arsenic trioxide therapy for relapsed or refractory Japanese patients with acute promyelocytic leukemia

被引：0

作者：

Shigeno, K

Nakamura, S

Naito, K

Yoshida, H

Fujisawa, S

Shinjo, K

Fujita, Y

Matsui, H

Sahara, N

Takeshita, A

Ohno, R

Ohnishi, K

机构：

[1] Hamamatsu Univ Sch Med, Dept Med 3, Hamamatsu, Shizuoka 43131, Japan

[2] Aichi Canc Ctr Hosp, Nagoya, Aichi 464, Japan

来源：

BLOOD | 2002年 / 100卷 / 11期

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

4583

引用

页码：264B / 264B

页数：1

共 50 条

[1] Pharmacokinetics of arsenic species in Japanese patients with relapsed or refractory acute promyelocytic leukemia treated with arsenic trioxide
Fujisawa, Shinya
Ohno, Ryuzo
Shigeno, Kazuyuki
Sahara, Naohi
Nakamura, Satoki
Naito, Kensuke
Kobayashi, Miki
Shinjo, Kaori
Takeshita, Akihiro
Suzuki, Yoshinari
Hashimoto, Hisakuni
Kinoshita, Kenji
Shimoya, Masahito
Kaise, Toshikazu
Ohnishi, Kazunori
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2007, 59 (04) : 485 - 493
[2] Pharmacokinetics of arsenic species in Japanese patients with relapsed or refractory acute promyelocytic leukemia treated with arsenic trioxide
Shinya Fujisawa
Ryuzo Ohno
Kazuyuki Shigeno
Naohi Sahara
Satoki Nakamura
Kensuke Naito
Miki Kobayashi
Kaori Shinjo
Akihiro Takeshita
Yoshinari Suzuki
Hisakuni Hashimoto
Kenji Kinoshita
Masahito Shimoya
Toshikazu Kaise
Kazunori Ohnishi
Cancer Chemotherapy and Pharmacology, 2007, 59 : 485 - 493
[3] Arsenic trioxide therapy for relapsed or refractory Japanese patients with acute promyelocytic leukemia: need for careful electrocardiogram monitoring
Ohnishi, K
Yoshida, H
Shigeno, K
Nakamura, S
Fujisawa, S
Naito, K
Shinjo, K
Fujita, Y
Matsui, H
Sahara, N
Takeshita, A
Satoh, H
Terada, H
Ohno, R
LEUKEMIA, 2002, 16 (04) : 617 - 622
[4] Arsenic trioxide therapy for relapsed or refractory Japanese patients with acute promyelocytic leukemia: need for careful electrocardiogram monitoring
K Ohnishi
H Yoshida
K Shigeno
S Nakamura
S Fujisawa
K Naito
K Shinjo
Y Fujita
H Matsui
N Sahara
A Takeshita
H Satoh
H Terada
R Ohno
Leukemia, 2002, 16 : 617 - 622
[5] Arsenic trioxide in the treatment of relapsed and refractory acute promyelocytic leukemia
Asou, N
INTERNAL MEDICINE, 2005, 44 (08) : 775 - 776
[6] Pharmacokinetics of arsenic trioxide (ATO) in patients with relapsed/refractory acute promyelocytic leukemia (APL).
Soignet, S
Bienvenu, B
Warrell, RP
Ellisson, R
Spriggs, D
Brannan, M
CLINICAL CANCER RESEARCH, 2000, 6 : 4534S - 4534S
[7] Pharmacokinetics of arsenic species with relapsed or refractory acute promyelocytic leukemia (APL) treated with arsenic trioxide (ATO) in Japanese patients.
Shigeno, K
Kobayashi, M
Sahara, N
Nakamura, S
Fujisawa, S
Naito, K
Shinjo, K
Takeshita, A
Ohno, R
Kinoshita, K
Shimoya, M
Kaise, T
Ohnishi, K
BLOOD, 2005, 106 (11) : 185B - 185B
[8] Arsenic trioxide therapy in relapsed or refractory Japanese patients with acute promyelocytic leukemia: Updated outcomes of the phase II study and postremission therapies
Shigeno, K
Naito, K
Sahara, N
Kobayashi, M
Nakamura, S
Fujisawa, S
Shinjo, K
Takeshita, A
Ohno, R
Ohnishi, K
INTERNATIONAL JOURNAL OF HEMATOLOGY, 2005, 82 (03) : 224 - 229
[9] Arsenic Trioxide Therapy in Relapsed or Refractory Japanese Patients with Acute Promyelocytic Leukemia: Updated Outcomes of the Phase II Study and Postremission Therapies
Kazuyuki Shigeno
Kensuke Naito
Naohi Sahara
Miki Kobayashi
Satoki Nakamura
Sinya Fujisawa
Kaori Shinjo
Akihiro Takeshita
Ryuzo Ohno
Kazunori Ohnishi
International Journal of Hematology, 2005, 82 : 224 - 229
[10] Arsenic trioxide therapy for relapsed acute promyelocytic leukemia: a bridge to transplantation
Leoni, F
Gianfaldoni, G
Annunziata, M
Fanci, R
Ciolli, S
Nozzoli, C
Ferrara, F
HAEMATOLOGICA, 2002, 87 (05) : 485 - 489

← 1 2 3 4 5 →